title: [Innovation in health care: the role of HTA in the introduction of new technologies].
abstract: Innovation in health care is a complex process taking place within a network of different stakeholders. From their specific perspective they need to continuously assess the technology under consideration to make the necessary decisions about the development and adoption of the technology. This is supported by HTA, but mainly with regard to reimbursement. Other important decisions are far less likely to be underpinned with evidence. The availability of data for both the decision criteria and the structures of decision-making processes have a role in this context. In the present contribution, we discuss the role of HTA in the innovation process. Amendments to assessment criteria, in particular from the perspective of patients, health care professionals, producers and macro-economics, are proposed to improve the basis for decisions of all relevant stakeholder groups.
authors.affiliation: Universitäre Psychiatrische Kliniken Basel, Basel, Schweiz. bernhard.buehrlen@upkbs.ch
authors.forename: Bernhard
authors.initials: B
authors.lastname: Bührlen
mesh_terms: D035843:Biomedical Research / Q000379:methods; D020811:Biomedical Technology / Q000379:methods*; D057189:Checklist; D032921:Consensus; D004059:Diffusion of Innovation; D005060:Europe; D005062:European Union; D019317:Evidence-Based Medicine / Q000379:methods*; D005544:Forecasting; D006801:Humans; D009313:National Health Programs; D013673:Technology Assessment, Biomedical / Q000379:methods*